Topical Botanical Drug Coacillium Curbs Childhood Alopecia
This site is intended for healthcare professionals

Topical Botanical Drug Coacillium Curbs Childhood Alopecia

Sara Freeman

October 12, 2023

0

Considerable hair regrowth can be achieved in children with alopecia areata with the use of a novel plant-based drug, according to research presented during the first late-breaking news session at the annual meeting of the European Academy of Dermatology and Venereology.

In the RAAINBOW study, a greater mean relative improvement in the Severity of Alopecia Tool (SALT) scores at 24 weeks was recorded in children who had been treated topically with coacillium (22.9%) than in those who had received a topical placebo (-8.0%), with a significant 31% overall difference (P < .0001).

"Coacillium cutaneous solution was used for the first time for treatment of alopecia areata and also for the first time used in a pediatric population," the presenting investigator Ulrike Blume-Peytavi, MD, said at the meeting.

"It's well tolerated, and in fact what is interesting is, it has a durable response, even after treatment discontinuation," added Blume-Peytavi, who is the deputy head of the Department of Dermatology, Venerology and Allergology at Charité-Universitätsmedizin Berlin in Germany.

Backing the Botanical?

Paola Pasquali, MDa dermatologist at Pius Hospital de Valls in Spain, who co-chaired the session where the findings were presented, commented, "Thank you for showing that chocolate is great! I knew it.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....